These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22645203)

  • 1. Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession.
    Ubachs JF; Sörensson P; Engblom H; Carlsson M; Jovinge S; Pernow J; Arheden H
    Eur Heart J Cardiovasc Imaging; 2012 Dec; 13(12):1008-15. PubMed ID: 22645203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction.
    Nordlund D; Klug G; Heiberg E; Koul S; Larsen TH; Hoffmann P; Metzler B; Erlinge D; Atar D; Aletras AH; Carlsson M; Engblom H; Arheden H
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):744-53. PubMed ID: 27002140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection.
    Ubachs JF; Engblom H; Erlinge D; Jovinge S; Hedström E; Carlsson M; Arheden H
    J Cardiovasc Magn Reson; 2010 Mar; 12(1):18. PubMed ID: 20350309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.
    Hansen ESS; Pedersen SF; Pedersen SB; Bøtker HE; Kim WY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1039-1045. PubMed ID: 30852704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction.
    Nordlund D; Kanski M; Jablonowski R; Koul S; Erlinge D; Carlsson M; Engblom H; Aletras AH; Arheden H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):12. PubMed ID: 28132648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging.
    Nordlund D; Heiberg E; Carlsson M; Fründ ET; Hoffmann P; Koul S; Atar D; Aletras AH; Erlinge D; Engblom H; Arheden H
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27412659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores.
    De Palma R; Sörensson P; Verouhis D; Pernow J; Saleh N
    J Cardiovasc Magn Reson; 2017 Jul; 19(1):55. PubMed ID: 28750637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective assessment of at-risk myocardium in reperfused acute myocardial infarction patients using contrast-enhanced balanced steady-state free-precession cardiovascular magnetic resonance at 3T with SPECT validation.
    Sun Z; Zhang Q; Zhao H; Yan C; Yang HJ; Li D; Li K; Liu Z; Yang Q; Dharmakumar R
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):25. PubMed ID: 33715636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography.
    Sörensson P; Heiberg E; Saleh N; Bouvier F; Caidahl K; Tornvall P; Rydén L; Pernow J; Arheden H
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):25. PubMed ID: 20433716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction.
    Eitel I; Kubusch K; Strohm O; Desch S; Mikami Y; de Waha S; Gutberlet M; Schuler G; Friedrich MG; Thiele H
    Circ Cardiovasc Imaging; 2011 Jul; 4(4):354-62. PubMed ID: 21518773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.
    Tufvesson J; Carlsson M; Aletras AH; Engblom H; Deux JF; Koul S; Sörensson P; Pernow J; Atar D; Erlinge D; Arheden H; Heiberg E
    BMC Med Imaging; 2016 Mar; 16():19. PubMed ID: 26946139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the myocardial area at risk: comparing T2-weighted cardiovascular magnetic resonance imaging with contrast-enhanced cine (CE-SSFP) imaging-a DANAMI3 substudy.
    Göransson C; Ahtarovski KA; Kyhl K; Lønborg J; Nepper-Christensen L; Bertelsen L; Ghotbi AA; Schoos MM; Køber L; Høfsten D; Helqvist S; Kelbæk H; Engstrøm T; Vejlstrup N
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):361-366. PubMed ID: 30085055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardium at risk in ST-segment elevation myocardial infarction comparison of T2-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring.
    Fuernau G; Eitel I; Franke V; Hildebrandt L; Meissner J; de Waha S; Lurz P; Gutberlet M; Desch S; Schuler G; Thiele H
    JACC Cardiovasc Imaging; 2011 Sep; 4(9):967-76. PubMed ID: 21920334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols.
    Lønborg J; Vejlstrup N; Mathiasen AB; Thomsen C; Jensen JS; Engstrøm T
    J Cardiovasc Magn Reson; 2011 Sep; 13(1):50. PubMed ID: 21917186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging.
    Lønborg J; Engstrøm T; Mathiasen AB; Vejlstrup N
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1455-64. PubMed ID: 21971845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardium at risk can be determined by ex vivo T2-weighted magnetic resonance imaging even in the presence of gadolinium: comparison to myocardial perfusion single photon emission computed tomography.
    Ubachs JF; Engblom H; Koul S; Kanski M; Andersson P; van der Pals J; Carlsson M; Erlinge D; Arheden H
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):261-8. PubMed ID: 22822155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2-weighted cardiac MR assessment of the myocardial area-at-risk and salvage area in acute reperfused myocardial infarction: comparison of state-of-the-art dark blood and bright blood T2-weighted sequences.
    Viallon M; Mewton N; Thuny F; Guehring J; O'Donnell T; Stemmer A; Bi X; Rapacchi S; Zuehlsdorff S; Revel D; Croisille P
    J Magn Reson Imaging; 2012 Feb; 35(2):328-39. PubMed ID: 21959873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT.
    Langhans B; Nadjiri J; Jähnichen C; Kastrati A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1357-63. PubMed ID: 24984612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.
    Carlsson M; Ubachs JF; Hedström E; Heiberg E; Jovinge S; Arheden H
    JACC Cardiovasc Imaging; 2009 May; 2(5):569-76. PubMed ID: 19442942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical feasibility study for detection of myocardial oedema by a cine SSFP sequence in comparison to a conventional T2-weighted sequence.
    Steen H; Voss F; André F; Neizel M; Schäufele T; Lehrke S; Lossnitzer D; Giannitsis E; Katus HA
    Clin Res Cardiol; 2012 Feb; 101(2):125-31. PubMed ID: 22038389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.